Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00202891Phase 4Withdrawn
A Phase 4 trial of sisomicin in Pyoderma, sponsored by Merck & Co.. Planned start May 2007; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00202891.